Breaking News! The Centers for Medicare and Medicaid Services (CMS) has announced a groundbreaking directive requiring Medicare Advantage plans to approve coverage for Qalsody, a treatment for individuals living with genetic SOD1-ALS. This milestone is a direct result of our collective advocacy for research, approval, and accessibility of life-changing treatments like Qalsody. This decision marks a significant step in accelerating access to ALS treatments, helping to ensure that those living wit